Lab-Grown Meat: FDA Approves Chicken Sale

For decades, science fiction writers have predicted a future where we eat meat without slaughtering animals. That future has officially arrived in the United States. Following rigorous safety reviews, the Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) have cleared the way for the sale of lab-grown chicken. While this regulatory green light marks a historic shift in food science, the industry faces immediate challenges regarding scalability, price, and public perception.

The Historic Approval of Cultivated Meat

In June 2023, the United States became the second country in the world, following Singapore, to approve the sale of cultivated meat. Two California-based companies, Upside Foods and Good Meat, received the final “Grant of Inspection” from the USDA. This was the final step in a multi-year regulatory marathon.

Prior to this, both companies had to clear the FDA’s safety hurdles. The FDA issued a “No Questions” letter, essentially stating they agreed with the companies’ conclusion that their cultivated chicken is safe for human consumption.

This approval is significant because it establishes a regulatory framework for a new industry. It differentiates “cell-cultivated” products from plant-based alternatives like Impossible Foods or Beyond Meat. While plant-based burgers rely on soy, peas, and wheat to mimic meat, the products from Upside Foods and Good Meat are biologically identical to chicken. They are made from actual animal cells, just grown outside the bird.

From Bioreactor to Plate: How It Works

To understand the product, you have to understand the science. The process begins with a small sample of cells taken from a live animal or a fertilized egg. In the case of Upside Foods, they have isolated cells that can grow predictably and robustly.

These cells are placed in large steel vessels known as bioreactors or cultivators. The environment inside these tanks mimics the body of a chicken. The cells are fed a nutrient-rich soup containing:

  • Amino acids
  • Sugars
  • Salts
  • Vitamins

Over a period of two to three weeks, the cells multiply exponentially. Once there is enough biomass, the meat is harvested. At this stage, it often resembles a paste or ground meat. To create structured cuts like a chicken breast or filet, companies use edible scaffolding or specialized molding techniques to align the cells, giving the final product the texture consumers expect from traditional poultry.

The First Locations to Serve Lab-Grown Chicken

You cannot walk into a Kroger or Walmart and buy a package of Upside Foods chicken today. The current production volume is tiny compared to the billions of chickens processed annually in the traditional agricultural system. Consequently, the rollout is extremely limited and high-end.

To build prestige and trust, both companies launched with celebrity chefs:

  • Upside Foods partnered with Dominique Crenn. Her three-Michelin-starred restaurant, Atelier Crenn, does not serve meat, but she made an exception for this product. It debuted at her venue Bar Crenn in San Francisco.
  • Good Meat partnered with JosĂ© AndrĂ©s. The product launched at his restaurant, China Chilcano, located in Washington, D.C.

These initial launches serve as tasting demonstrations rather than mass-market retail. They allow the companies to showcase the product in a controlled, culinary-focused environment.

The Economic Hurdle: Production Costs

The snippet provided highlights a critical issue: production costs. Traditional chicken is one of the cheapest forms of protein available, often costing consumers between \(2 and \)5 per pound. In contrast, the technology required to produce cultivated meat is expensive.

In the early days of development, a single pound of lab-grown meat cost thousands of dollars to produce. While costs have dropped dramatically, they remain significantly higher than conventional agriculture. Several factors keep the price high:

  • Growth Medium: The nutrient bath required to feed the cells is costly. Historically, this relied on fetal bovine serum (FBS), which is expensive and ethically controversial. Companies have moved toward animal-free nutrient mixes, but these specialized pharmaceutical-grade formulas are still pricey.
  • Energy Consumption: Bioreactors require constant temperature control and aeration. This energy intensity creates a high operating cost compared to a chicken coop.
  • Infrastructure: Building a facility capable of producing millions of pounds of meat requires hundreds of millions of dollars in capital investment.

Until companies can scale up to massive industrial levels, they will likely sell their products at a loss or at a premium luxury price point.

Consumer Appetite and The "Yuck" Factor

Beyond the price tag, the industry faces a psychological barrier. The snippet mentions “consumer appetite,” which refers to the public’s willingness to eat meat grown in a steel tank.

Recent polls suggest a divide in public opinion. A 2023 AP-NORC poll found that half of U.S. adults said they were unlikely to try meat grown from animal cells. Common concerns include:

  • Naturalness: Skepticism about whether the food is “natural” or highly processed.
  • Safety: despite FDA approval, new food technology often breeds caution.
  • Flavor and Texture: Fear that the meat will feel artificial or lack the depth of flavor found in farm-raised meat.

Labeling plays a major role here. The USDA requires clear labeling so consumers know they are buying “cell-cultivated” or “cell-cultured” chicken, ensuring they do not confuse it with slaughtered poultry. The industry is banking on the environmental and ethical benefits (no slaughter, lower land use) to win over younger generations like Gen Z and Millennials, who statistically show more interest in sustainable food systems.

The Environmental Promise vs. Reality

One of the primary selling points for cultivated meat is sustainability. Traditional livestock agriculture is a major contributor to greenhouse gas emissions, land degradation, and water pollution. Theoretically, lab-grown meat solves this by removing the animal from the equation.

However, the current reality is nuanced. A study from the University of California, Davis, suggested that if the industry uses highly refined pharmaceutical-grade growth media, the carbon footprint of lab-grown meat could actually be higher than traditional beef due to the energy required to purify those ingredients.

To meet their environmental promises, Upside Foods, Good Meat, and others must transition to food-grade ingredients and renewable energy sources for their facilities. If they can solve the energy equation, the potential to reduce agricultural land usage is massive.

Frequently Asked Questions

Is lab-grown chicken vegan? No. It is made from actual animal cells. While no animal is slaughtered in the production process, it is biologically meat. People with chicken allergies should not eat it.

Is it safe to eat? Yes. The FDA conducted a thorough pre-market consultation and found no safety concerns. The USDA also inspects the production facilities, just as they do for traditional slaughterhouses.

When will I see this in grocery stores? It will likely be several years before cell-cultivated meat is widely available in supermarkets. The industry needs to build large-scale infrastructure to lower the price enough to compete with conventional chicken.

Does it taste like real chicken? Yes, because it is real chicken. Early reviews from Bar Crenn and China Chilcano indicate that the texture and flavor are nearly indistinguishable from conventional poultry, though the texture can vary depending on how the cells are structured during production.